https://www.ema.europa.eu/en/homepageScientific guidelines (human and veterinary)en-gbCopyright: (C) European Medicines AgencyFri, 26 Apr 2024 01:09:55 +0200Thu, 18 Apr 2024 11:31:51 +0200https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-good-agricultural-collection-practice-gacp-starting-materials-herbal-origin-revision-1_en.pdfDraft guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin - Revision 1https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-good-agricultural-collection-practice-gacp-starting-materials-herbal-origin-revision-1_en.pdfThu, 18 Apr 2024 11:31:51 +0200Scientific guidelines (human and veterinary)https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmaceutical-quality-inhalation-nasal-medicinal-products_en.pdfDraft guideline on the pharmaceutical quality of inhalation and nasal medicinal productshttps://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmaceutical-quality-inhalation-nasal-medicinal-products_en.pdfFri, 12 Apr 2024 10:03:09 +0200Scientific guidelines (human and veterinary)https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-requirements-demonstrating-therapeutic-equivalence-between-orally-inhaled-products-oip-asthma-chronic-obstructive-pulmonary-disease-copd_en.pdfDraft guideline on the requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD)https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-requirements-demonstrating-therapeutic-equivalence-between-orally-inhaled-products-oip-asthma-chronic-obstructive-pulmonary-disease-copd_en.pdfFri, 12 Apr 2024 09:12:50 +0200Scientific guidelines (human and veterinary)